loadpatents
name:-0.019828081130981
name:-0.0081648826599121
name:-0.00046992301940918
Brodney; Michael A. Patent Filings

Brodney; Michael A.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Brodney; Michael A..The latest application filed is for "novel lactams as beta secretase inhibitors".

Company Profile
0.7.17
  • Brodney; Michael A. - East Lyme CT
  • Brodney; Michael A. - Old Lyme CT
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Novel Lactams as Beta Secretase Inhibitors
App 20110224231 - Brodney; Michael A. ;   et al.
2011-09-15
Imidazole compounds for the treatment of neurodegenerative disorders
Grant 7,951,958 - Brodney , et al. May 31, 2
2011-05-31
Novel Class of Spiro Piperidines for the Treatment of Neurodegenerative Diseases
App 20110046160 - Brodney; Michael A. ;   et al.
2011-02-24
Pyrimidone Compounds As GSK-3 Inhibitors
App 20100292205 - Lefker; Bruce A. ;   et al.
2010-11-18
Imidazole compounds for the treatment of neurodegenerative disorders
Grant 7,795,447 - Brodney , et al. September 14, 2
2010-09-14
Imidazole compounds for the treatment of neurological disorders
Grant 7,781,435 - Brodney , et al. August 24, 2
2010-08-24
Imidazole Compounds For The Treatment Of Neurological Disorders
App 20100184737 - Brodney; Michael A. ;   et al.
2010-07-22
Imidazole Compounds For The Treatment Of Neurodegenerative Disorders
App 20100168107 - Brodney; Michael A. ;   et al.
2010-07-01
Benzimidazolyl Compounds
App 20080280933 - Efremov; Ivan ;   et al.
2008-11-13
Imidazole Compounds For The Treatment Of Neurodegenerative Disorders
App 20080227781 - Brodney; Michael A. ;   et al.
2008-09-18
Pyridyloxymethyl and benzisoxazole azabicyclic derivatives
Grant 7,345,038 - Bright , et al. March 18, 2
2008-03-18
Sulfonamide compounds for the treatment of neurodegenerative disorders
Grant 7,345,095 - Brodney , et al. March 18, 2
2008-03-18
Imidazole compounds for the treatment of neurodegenerative disorders
Grant 7,342,118 - Brodney , et al. March 11, 2
2008-03-11
Sulfonamide Compounds For The Treatment Of Neurodegenerative Disorders
App 20070129349 - Brodney; Michael A. ;   et al.
2007-06-07
Imidazole compounds for the treatment of neurological disorders
App 20070066613 - Brodney; Michael A. ;   et al.
2007-03-22
Sulfonamide compounds for the treatment of neurodegenerative disorders
Grant 7,163,942 - Brodney , et al. January 16, 2
2007-01-16
Pyridyl piperazines for the treatment of CNS disorders
App 20060025421 - Brodney; Michael A.
2006-02-02
Tetrahydronaphthylpiperazines as 5HT1B antagonists, inverse agonists and partial agonists
App 20050288304 - Brodney, Michael A. ;   et al.
2005-12-29
Combination of atypical antipsychotics and 5HT-1B receptor antagonists
App 20050256112 - Brodney, Michael A. ;   et al.
2005-11-17
Novel benayl(idene)-lactam derivatives
App 20050245521 - Brodney, Michael A. ;   et al.
2005-11-03
Sulfonamide compounds for the treatment of neurodegenerative disorders
App 20050222254 - Brodney, Michael A. ;   et al.
2005-10-06
Imidazole compounds for the treatment of neurodegenerative disorders
App 20050215610 - Brodney, Michael A. ;   et al.
2005-09-29
Compositions for treating CNS disorders
App 20050171086 - Brodney, Michael A. ;   et al.
2005-08-04
Pyridyloxymethyl and benzisoxazole azabicyclic derivatives
App 20050026922 - Bright, Gene Michael ;   et al.
2005-02-03

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed